These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 29805751)
1. The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Zocchi L; Wu SC; Wu J; Hayama KL; Benavente CA Oncotarget; 2018 May; 9(34):23505-23518. PubMed ID: 29805751 [TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines. Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542 [TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells. Li Y; Tanaka K; Li X; Okada T; Nakamura T; Takasaki M; Yamamoto S; Oda Y; Tsuneyoshi M; Iwamoto Y Int J Cancer; 2007 Sep; 121(6):1212-8. PubMed ID: 17520676 [TBL] [Abstract][Full Text] [Related]
4. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Raju U; Nakata E; Mason KA; Ang KK; Milas L Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657 [TBL] [Abstract][Full Text] [Related]
5. Rhabdoid tumor growth is inhibited by flavopiridol. Smith ME; Cimica V; Chinni S; Challagulla K; Mani S; Kalpana GV Clin Cancer Res; 2008 Jan; 14(2):523-32. PubMed ID: 18223228 [TBL] [Abstract][Full Text] [Related]
6. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955 [TBL] [Abstract][Full Text] [Related]
7. Flavopiridol-induced apoptosis during S phase requires E2F-1 and inhibition of cyclin A-dependent kinase activity. Jiang J; Matranga CB; Cai D; Latham VM; Zhang X; Lowell AM; Martelli F; Shapiro GI Cancer Res; 2003 Nov; 63(21):7410-22. PubMed ID: 14612540 [TBL] [Abstract][Full Text] [Related]
8. Alvocidib inhibits IRF4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth. Sakamoto H; Ando K; Imaizumi Y; Mishima H; Kinoshita A; Kobayashi Y; Kitanosono H; Kato T; Sawayama Y; Sato S; Hata T; Nakashima M; Yoshiura KI; Miyazaki Y Cancer Sci; 2022 Dec; 113(12):4092-4103. PubMed ID: 36047964 [TBL] [Abstract][Full Text] [Related]
9. Flavopiridol enhances the effect of docetaxel in vitro and in vivo in human gastric cancer cells. Motwani M; Rizzo C; Sirotnak F; She Y; Schwartz GK Mol Cancer Ther; 2003 Jun; 2(6):549-55. PubMed ID: 12813134 [TBL] [Abstract][Full Text] [Related]
10. Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol. Shapiro GI Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4270s-4275s. PubMed ID: 15217973 [TBL] [Abstract][Full Text] [Related]
11. Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. Sabile AA; Arlt MJ; Muff R; Bode B; Langsam B; Bertz J; Jentzsch T; Puskas GJ; Born W; Fuchs B J Bone Miner Res; 2012 Jan; 27(1):58-67. PubMed ID: 21976359 [TBL] [Abstract][Full Text] [Related]
12. Flavopiridol and trastuzumab synergistically inhibit proliferation of breast cancer cells: association with selective cooperative inhibition of cyclin D1-dependent kinase and Akt signaling pathways. Wu K; Wang C; D'Amico M; Lee RJ; Albanese C; Pestell RG; Mani S Mol Cancer Ther; 2002 Jul; 1(9):695-706. PubMed ID: 12479366 [TBL] [Abstract][Full Text] [Related]
13. Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Shapiro GI; Koestner DA; Matranga CB; Rollins BJ Clin Cancer Res; 1999 Oct; 5(10):2925-38. PubMed ID: 10537362 [TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo. Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294 [TBL] [Abstract][Full Text] [Related]